Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

A new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, "Linking FOXM1 and PD-L1 to CDK4/6 ...

Foods containing certain dye additives can no longer be sold in California schools—and other states could follow.

A network of illegal drug sellers based in the U.S., the Dominican Republic and India packaged potentially deadly synthetic ...

Many who have schizophrenia don’t respond to antipsychotic drugs. That’s why experts are cheering the US Food and Drug ...

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic- ...

NIPER Rae Bareli celebrated its 9th annual convocation, conferring degrees to 114 students, including MS Pharma and PhD graduates. Key highlights include gold medal awards, remarks from industry ...

When PGA Tour player Sam Ryder found himself six over par through eight holes in the first round of the Honda Classic, he ...

"Working with Dr. Stoops and his lab have given me an unbelievable foundation for clinical research. I've gotten to learn all about pharmacology of drugs, how they work, how they affect the brain - ...

The number of Marylanders dying from overdoses fell over the past year, mirroring a national trend but lagging behind the ...

Patient Special Access Program continues during Health Canada reviewMELBOURNE, Australia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- ...